MBRX

Moleculin Biotech, Inc. - Common Stock (MBRX)

About Moleculin Biotech, Inc. - Common Stock (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high

$0.90

Daily low

$0.71

Price at open

$0.85

52 Week High

$15.75

52 Week Low

$0.16

Market cap

16.2M

Dividend yield

Volume

1.9M

Avg. volume

671,968

P/E ratio

-.05

Moleculin Biotech, Inc. - Common Stock News